Stability of Albuterol in Continuous Nebulization
Author(s): Hunter Dee A, Yoo Sun D, Fox Janet L, Michniak Bozena B
Issue: Sep/Oct 1998 - Parenteral Nutrition Solutions
View All Articles in Issue
Page(s): 394-396
Download in electronic PDF format for $75
Abstract: Due to the emergent nature of situations requiring continuous nebulization of albuterol, a premixed albuterol solution would provide faster access to the therapy when required. The purpose of this study was to evaluate the stability of albuterol solutions at a concentration (200 µg/mL) used in continuous nebulization when stored in various containers of polyvinyl chloride bags, polyolefin bags, polypropylene syringes and tubes and borosilicate glass tubes. Solutions were prepared in triplicate in 0.9% sodium chloride stored under refrigerated and room temperatures for seven days. Samples were removed and analyzed using a stability-indicating high-performance liquid chromatography assay method. Albuterol was found to be stable (>90% of the initial concentration remaining) for at least seven days in all five types of containers under the conditions tested.